Showing results (921-930 of 1,677) with videos related to
Sort By:
Pageof 168
European Urology|September 12, 2024
Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial CancerLuca Afferi, Alessia Cimadamore, Andrea Gallioli, et al.Urology|October 12, 2010
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinomaMaxime Crépel, Claudio Jeldres, Maxine Sun, et al.BJU International|September 24, 2010
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based studyDaniel Liberman, Ahmed Alasker, Maxine Sun, et al.Endocrine Connections|June 11, 2020
SHBG levels in primary infertile men: a critical interpretation in clinical practiceLuca Boeri, Paolo Capogrosso, Walter Cazzaniga, et al.BJU International|April 22, 2011
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomyFiras Abdollah, Maxine Sun, Alberto Briganti, et al.European Urology|May 24, 2011
The contemporary concept of significant versus insignificant prostate cancerGuillaume Ploussard, Jonathan I Epstein, Rodolfo Montironi, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 20, 2014
Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) databaseGiorgio Gandaglia, Briony Varda, Akshay Sood, et al.Journal of Endourology|May 10, 2018
The Effect of Institution Teaching Status on Perioperative Outcomes After Robotic Partial or Radical NephrectomyMichele Marchioni, Sebastiano Nazzani, Felix Preisser, et al.European Urology Focus|December 31, 2018
Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based StudyFelix Preisser, Elio Mazzone, Sebastiano Nazzani, et al.Clinical Genitourinary Cancer|October 4, 2025
Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome InterpretationDaniele Robesti, Filippo Micheli, Shesh N Rai, et al.Pageof 168